(CB-03-01 Vehicle Research) PhD Student in Chemistry

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • TravisB
    replied
    Originally posted by Alias123
    so the treatment for acne is expected this year or what? if you say that we can trust their pipeline...
    No

    Cosmo will start phase III trials this year.

    Phase III should take up to 2 years I think, and if CB passes Phase III, then FDA must review and approve the drug (it also takes up to 2 years), and then it can be marketed.

    I think we will see CB for acne on the shelves in 2018 max, and 1-2 years later the MPB version.

    It's not that far really if you think about it. 2018 is only 4 years away . And IMO it's the worst case because it can come in 2017 or even 2016.

    But again I don't know shit and it's just my opinion + a bit of wishful thinking

    Leave a comment:


  • Alias123
    replied
    so the treatment for acne is expected this year or what? if you say that we can trust their pipeline...

    Leave a comment:


  • Dan26
    replied
    Originally posted by mikeswick
    is CB for maintenance of what you already have? or does it regrow hair?
    will depend on the person...like fin/dut, mostly for maintanence but could get regrowth. Preliminary trials (iontophereis ones) showed good regrowth

    Leave a comment:


  • mikeswick
    replied
    Originally posted by Pentarou
    True! The acne version of CB-03-01 hitting the market will be a Big Deal, that will indicate that 99.99% of the battle is already won. At worst then, that will mean that CB will be widely available off-licence/off-label for hair loss treatment purposes like Avodart has been for the last decade.
    is CB for maintenance of what you already have? or does it regrow hair?

    Leave a comment:


  • Pentarou
    replied
    Originally posted by LMS
    straight up, who cares about the alopecia version. when the acne version hits shelves, damn straight we reverse engineering that bitch and making our own super powerful shit.

    but until then its fin + ru.

    such is life.
    True! The acne version of CB-03-01 hitting the market will be a Big Deal, that will indicate that 99.99% of the battle is already won. At worst then, that will mean that CB will be widely available off-licence/off-label for hair loss treatment purposes like Avodart has been for the last decade.

    Leave a comment:


  • TravisB
    replied
    Also quote from Cosmo website:

    An IND was granted in the US for CB-03-01 for acne in Q1 2012. Phase II dose escalating clinical trials were initiated in the US in H2 2012 and are scheduled to be completed in H1 2014. An IND is planned to be filed for alopecia in H1 2014.
    And quote from CB alopecia presentation

    Pre-IND meeting held on 18 Dec 13, full FDA agreement on
    development program
    So now let's look at that - in Q1 2012 an IND (Investigational New Drug) was granted for CB for acne, and 2 years later (this year) they will probably be starting Phase III.

    This year an IND will also be granted for CB for alopecia, so if everything went same way, phase III trials would be starting in 2016. This IMO would make year 2018-2019 very realistic for the release of CB for alopecia. Perhaps the things could be speeded up even more if acne CB went on the market and was proven to be a safe and well studied substance.

    I'm positive about Cosmo because from their pipeline I see they meet their deadlines and don't delay things.

    Actually according to their pipeline, Phase II POC (proof of concept) stage for CB for alopecia is going to end in H1/2015. But does anyone know how POC stage differs from an ordinary Phase II? Because looking at their pipeline it's the same

    Leave a comment:


  • cookies
    replied
    Originally posted by HairBane
    Also, what does the 'phase i clinical study in EU completed' part mean?
    That they completed phase 1 of their clinical study in the EU? Which I find a bit confusing, since their other data seem to indicate that they're in an earlier stage of their clinical study, but I'm no expert.

    Leave a comment:


  • cookies
    replied
    There are no big revelations, but no bad news either.

    They mention that their vehicle for acne treatement is QD or BID, but I have no idea what these abbrevations stand for, but it will be a cream. I'm not sure if you can put that on your head.

    Leave a comment:


  • TravisB
    replied
    Originally posted by yan
    Today`s cosmo-presentation is a bit disappointing...

    Only info about cb for alopecia is this:

    Pre clinical:
    - Pre-clinical development on mini-pigs (6 and 9 months) to obtain the chronic use of the drug;
    - last tolerability test ongoing

    clinical:
    - phase I clinical study in EU completed
    - PK results: ˂1% API absorption into the blood = topical drug
    - Phase II POC: design with 3 arms (drug, placebo, comparator), 6 months treatment + follow up, male pts only

    regulatory:
    - Pre-IND meeting held on 18 Dec 13, full FDA agreement on development program

    http://www.cosmopharma.com/~/media/F...ainate2014.pdf
    What's so disappointing in this? At least we know that they are moving forward.

    Also the acne version phase III trials will probably start this year.

    I think acne version has the chance to hit the market in 2016-2017, but I'm not sure about alopecia version. Maybe it will hit the market before 2020, if ever.

    But if acne version turns out to be also effective for MPB, then we're all good

    Leave a comment:


  • UK_
    replied
    Originally posted by staythick
    checking this forum everyday isn't helping me either. My hairloss is slow and minox is the only thing i got that has kept me steady and that doesn't say much. especially, since we are now in 2014 and i'm using the best treatment now that was available in the damn 80's. it's disgusting.

    Wish you the best everyone. I'm done with this forum. Time to move on with my life and with the hair i got. My rant is done.

    Peace guys.
    lol!

    Leave a comment:


  • HairBane
    replied
    Originally posted by yan
    Today`s cosmo-presentation is a bit disappointing...

    Only info about cb for alopecia is this:

    Pre clinical:
    - Pre-clinical development on mini-pigs (6 and 9 months) to obtain the chronic use of the drug;
    - last tolerability test ongoing

    clinical:
    - phase I clinical study in EU completed
    - PK results: ˂1% API absorption into the blood = topical drug
    - Phase II POC: design with 3 arms (drug, placebo, comparator), 6 months treatment + follow up, male pts only

    regulatory:
    - Pre-IND meeting held on 18 Dec 13, full FDA agreement on development program

    http://www.cosmopharma.com/~/media/F...ainate2014.pdf
    Yes there's a lack of info, but at least it seems like they're getting good safety and efficacy with acne and progressing to phase 3. I wasn't really expecting vehicle info, the most they've said so far is that PG/OL gave like 100x penetration, so why not use that?

    Also, what does the 'phase i clinical study in EU completed' part mean?

    Leave a comment:


  • LMS
    replied
    straight up, who cares about the alopecia version. when the acne version hits shelves, damn straight we reverse engineering that bitch and making our own super powerful shit.

    but until then its fin + ru.

    such is life.

    Leave a comment:


  • TwoInchCircle
    replied
    Originally posted by yan
    Today`s cosmo-presentation is a bit disappointing...
    To say the LEAST. The first thing I did this morning was head over to Cosmo's site to check it out and I couldn't believe what I was seeing. At first, I thought it might be an outline to their real presentation, but, sadly, it is the real presentation.

    I wasn't expecting them to spill all their secrets regarding vehicles and such, but I was expecting a little more information on whether the trials' success and such...

    Oh well...

    Leave a comment:


  • yan
    replied
    Today`s cosmo-presentation is a bit disappointing...

    Only info about cb for alopecia is this:

    Pre clinical:
    - Pre-clinical development on mini-pigs (6 and 9 months) to obtain the chronic use of the drug;
    - last tolerability test ongoing

    clinical:
    - phase I clinical study in EU completed
    - PK results: ˂1% API absorption into the blood = topical drug
    - Phase II POC: design with 3 arms (drug, placebo, comparator), 6 months treatment + follow up, male pts only

    regulatory:
    - Pre-IND meeting held on 18 Dec 13, full FDA agreement on development program

    Leave a comment:


  • itssomuchfun
    replied
    Sorry Hellouser for the incorrect info. How many ml are you using? I started using it yesterday and it's impossible to use just 1ml for my entire scalp crown to vertex, at that is what I've found.

    Doke, I just ordered it from their website. Just google Iron Dragon. It's listed as Cortexolone 17-Alpha Propionate which is supposedly the same thing. I got it in about 10 days. Hopefully some of my hair loss starts to abate in the next month or two because I'm am pretty close to just shaving it off because it's very thin on top it's a few months away from looking pretty silly.

    Leave a comment:

Working...